TRANSFORMED HUMAN CELL AND USE THEREOF

The present invention relates to a transformed human cell and a use thereof and, more particularly, to a cell transformed with a gene for coding an MHC I cell membrane receptor and an MHC II cell membrane receptor by using a gene expression suppressing system using a guide RNA, and a use thereof. Su...

Full description

Saved in:
Bibliographic Details
Main Authors LEE, Jee Won, LEE, Yun Jung, KWON, Young Eun, KIM, Mun Kyung, LIM, Ok Jae, CHOE, Seung Hyon, KIM, Yu Young, YANG, Woo Seok
Format Patent
LanguageEnglish
French
Korean
Published 23.05.2019
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a transformed human cell and a use thereof and, more particularly, to a cell transformed with a gene for coding an MHC I cell membrane receptor and an MHC II cell membrane receptor by using a gene expression suppressing system using a guide RNA, and a use thereof. Such a transformed cell can effectively exhibit the therapeutic effect of cells even in vivo, and cannot be removed by an in vivo immune response. Therefore, it is expected that a composition comprising the immunocyte as an active ingredient can be usefully used for the treatment of cancer, infectious diseases, degenerative diseases or immunological diseases. La présente invention concerne une cellule humaine transformée et son utilisation et, plus particulièrement, une cellule transformée avec un gène pour coder pour un récepteur de la membrane cellulaire du CMH I et un récepteur de la membrane cellulaire du CMH II au moyen d'un système de suppression d'expression génique utilisant un ARN guide, ainsi que son utilisation. Une telle cellule transformée peut efficacement présenter l'effet thérapeutique de cellules même in vivo, et ne peut pas être éliminée par une réponse immunitaire in vivo. Par conséquent, il est prévu qu'une composition comprenant l'immunocyte en tant que principe actif peut être utilisé efficacement pour le traitement du cancer, de maladies infectieuses, de maladies dégénératives ou de maladies immunologiques. 본 발명은 형질전환된 인간세포 및 이의 용도에 관한 것으로, 보다 구체적으로 가이드 RNA를 이용한 유전자 발현 억제용 시스템을 이용한 MHC I 세포막 수용체 및 MHC II 세포막 수용체를 코딩하는 유전자가 변형된 세포 및 이의 용도에 관한 것이다. 상기와 같은 형질전환 세포는 생체 내에서도 세포의 치료 효능을 효과적으로 발휘할 수 있으며, 생체 내 면역반응에 의해 제거되지 않는다. 따라서, 상기 면역세포를 유효성분으로 포함하는 조성물은 암, 감염성 질환, 퇴행성 질환 또는 면역 질환 치료에 유용하게 활용될 수 있을 것으로 기대된다.
Bibliography:Application Number: WO2018KR14112